Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

12.41 +0.35 (+2.90%)

Delayed Quote Updated: 11:41 AM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Gold Falls 3%; Carter's Shares Gain After Q3 Earnings ↗

October 27, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

October 27, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗

October 27, 2025

Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.

Via Benzinga

Nasdaq Surges 300 Points; Keurig Dr Pepper Shares Jump After Q3 Results ↗

October 27, 2025

Via Benzinga

Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details ↗

September 19, 2025

Via Stocktwits

These stocks are moving in today's pre-market session ↗

October 27, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Why Did NTLA Stock Tumble 43% Pre-Market Today? ↗

October 27, 2025

Intellia said that it has temporarily paused patient dosing and screening for two of its late-stage trials for Nex-z.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges

October 21, 2025

The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic...

Via MarketMinute

4 Healthcare Stocks to Buy Now ↗

October 12, 2025

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Via The Motley Fool

Topics Artificial Intelligence

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗

October 08, 2025

Via Benzinga

1 Stock Up by 63% This Year That Could Double, According to Wall Street ↗

October 07, 2025

Some math suggests that even Wall Street is lowballing the stock's potential.

Via The Motley Fool

What Analysts Are Saying About Intellia Therapeutics Stock ↗

October 06, 2025

Via Benzinga

Navigating the Future: Unlocking Investment Opportunities in High-Growth Sectors

October 04, 2025

As of October 2025, the global financial markets are undergoing a profound transformation, driven by an accelerating wave of technological innovation and a pressing global imperative for...

Via MarketMinute

Topics Artificial Intelligence Climate Change Economy

Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design

October 02, 2025

London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented...

Via TokenRing AI

Topics Artificial Intelligence

Cathie Wood Goes Shopping: 3 Rising Stocks She Just Bought ↗

October 01, 2025

The growth investor kicked off this week buying up some high-flying stocks.

Via The Motley Fool

Topics Artificial Intelligence World Trade

Acuity, Lithium Americas, Rezolve AI, AES And Other Big Stocks Moving Higher On Wednesday ↗

October 01, 2025

Via Benzinga

Topics Artificial Intelligence

Intellia Highlights Clinical Improvements With One-Time Dose Of Experimental Drug ↗

September 25, 2025

Intellia Therapeutics Inc. (NASDAQ: NTLA) on Thursday released longer-term follow-up data from the ongoing Phase 1 study of investigational nexiguran ziclumeran (nex-z) for the treatment of hereditary...

Via Benzinga

The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market

September 19, 2025

The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday ↗

September 19, 2025

Via Benzinga

Expert Outlook: Intellia Therapeutics Through The Eyes Of 5 Analysts ↗

September 19, 2025

Via Benzinga

Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback ↗

September 18, 2025

Small-cap benchmark Russell 2000 ETF hits record high after Fed cuts rates, hinting at more cuts. Small caps rally 43% since tariff-driven selloff.

Via Benzinga

Topics ETFs Economy

Intellia Therapeutics Shares Are Ripping Higher: Here's Why ↗

September 18, 2025

Intellia Therapeutics Inc (NASDAQ:NTLA) shares are soaring on Thursday after the company completed enrollment in its crucial Phase 3 HAELO trial and laid out its key development milestones.

Via Benzinga

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 18, 2025

Via Benzinga

Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday ↗

September 18, 2025

Via Benzinga

Cathie Wood Goes Bargain Hunting: She Just Bought 2 Stocks That Wall Street Thinks Will Climb 50% and 190% ↗

September 11, 2025

These companies are reaching key milestones.

Via The Motley Fool

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Demystifying Intellia Therapeutics: Insights From 9 Analyst Reviews ↗

August 11, 2025

Via Benzinga

Walt Disney To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday ↗

August 11, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.